Title:
|
Survival outcomes and effect of early vs. deferred cART among HIV-infected patients diagnosed at the time of an AIDS-defining event: a cohort analysis.
|
Author:
|
Miró Meda, José M.; Manzardo, Christian; Mussini, C.; Johnson, Margaret M.; D'Arminio Monforte, Antonella; Antinori, A.; Gill, M.J.; Sighinolfi, L.; Uberti-Foppa, C.; Borghi, V.; Sabin, C.; Late Presenters Investigators.
|
Other authors:
|
Universitat de Barcelona |
Abstract:
|
Objectives: We analyzed clinical progression among persons diagnosed with HIV at the time of an AIDS-defining event, and assessed the impact on outcome of timing of combined antiretroviral treatment (cART). Methods: Retrospective, European and Canadian multicohort study.. Patients were diagnosed with HIV from 1997-2004 and had clinical AIDS from 30 days before to 14 days after diagnosis. Clinical progression (new AIDS event, death) was described using Kaplan-Meier analysis stratifying by type of AIDS event. Factors associated with progression were identified with multivariable Cox regression. Progression rates were compared between those starting early (< 30 days after AIDS event) or deferred (30-270 days after AIDS event) cART. Results: The median (interquartile range) CD4 count and viral load (VL) at diagnosis of the 584 patients were 42 (16, 119) cells/ mL and 5.2 (4.5, 5.7) log 10 copies/mL. Clinical progression was observed in 165 (28.3%) patients. Older age, a higher VL at diagnosis, and a diagnosis of non-Hodgkin lymphoma (NHL) (vs. other AIDS events) were independently associated with disease progression. Of 366 patients with an opportunistic infection, 178 (48.6%) received early cART. There was no significant difference in clinical progression between those initiating cART early and those deferring treatment (adjusted hazard ratio 1.32 [95% confidence interval 0.87, 2.00], p=0.20). Conclusions: Older patients and patients with high VL or NHL at diagnosis had a worse outcome. Our data suggest that earlier initiation of cART may be beneficial among HIV-infected patients diagnosed with clinical AIDS in our setting. |
Subject(s):
|
-VIH (Virus) -Sida -Antiretrovirals -Terapèutica -Persones seropositives -HIV (Viruses) -AIDS (Disease) -Antiretroviral agents -Therapeutics -HIV-positive persons |
Rights:
|
cc-by (c) Miro, J.M. et al., 2011
http://creativecommons.org/licenses/by/3.0/es |
Document type:
|
Article Article - Published version |
Published by:
|
Public Library of Science (PLoS)
|
Share:
|
|